Followers | 231 |
Posts | 14728 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Thursday, September 06, 2018 10:30:56 PM
For the unmethylated, since it was dashed, I filled in the lines with grey lines and that made it easier to count them.
I actually marked each event by number and I think it's fairly accurate.
Here's what I found:
OS events ≥ 36 months
Methylated: 65 (there are two more but they are after 36 months)
Unmethylated: 114
Total: 179 OS events prior ≤ 36 months
And you'll remember that I had 64 censored or presumably alive patients ≤ 36 months
Methylated: 39
Unmethylated: 25
So 179 OS events + 64 alive all prior to 36 months = 243 total patients
With 331 total patients in the trial minus 243 = 88 patients remaining
So it would appear there were 88 patients that have lived past 36 months thus far.
And are these patients that have determined the 88.2 km derived curve.
Since we think (you and I) that 44 patients were alive as of 3/17, it would seem that 44 had died. Of course, it's possible that I'm off by some number in the counts, but it seems obvious to me that there are well past 44 patients (not 2 or 3 as some have suggested) who have lived past 36 months at this time.
There were 162 total unmethylated patients in the trial minus approx. 114 who died minus approx. 25 alive or censored (both shown on chart) leaving approx. 23 unmethylated that lived ≥ 36 months as of 3/17.
There were 131 total methylated patients in the trial minus approx. 65 who died minus approx. 39 alive or censored (both shown on chart) leaving
approx. 27 methylated that lived ≥ 36 months as of 3/17.
Actually, it looks like unmethylated has done surprisingly better than what is typical. There were 23 who appear to have lived past 36 months with another 25 who were still alive between 18 and 36 months. By my estimations, about 17 of them should live to 36 months, which, if this is accurate, would be 23 + 17 = 40 / 162
= 25% unmethylated patients live ≥ 36 months.
From the NWBO press release for the journal, it had stated that the mOS for unmethylated GBM was 12.7 months. So if approx. 25% end up living past 36 months, that would really be impressive.
Here is the chart with the OS events and censored counts:
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM